convulsive seizure News
-
Worldwide first absence seizure tracker becomes available to Australian families
More than 250,000 people are living with epilepsy in Australia, of which 1 in 7 are having difficult-to-notice absence seizures. Such seizures are different from tonic-clonic (convulsive) seizures, and are typically shorter in length, with a brief loss of consciousness. Even though this type of seizure usually does not lead to physical injury, it has a major impact on the wellbeing of the person ...
By Epihunter NV
-
Brain Sentinel Announces Satellite Symposium at AES Annual Meeting in Baltimore, Maryland
Brain Sentinel, Inc. announces it is hosting a non-CME satellite symposium for healthcare professionals in Baltimore, Maryland at the AES Annual Meeting. The symposium, “Fundamentals of Quantitative Surface Electromyography (sEMG) for Long-Term Monitoring”, has 5 key learning objectives: Understand methods of quantitative sEMG analysis during ictal events; Review specific sEMG ...
-
Brain Sentinel Announces Launch of SeizureLink, its sEMG-Based Seizure Alerting System, Available Without a Prescription
Brain Sentinel Consumer Systems, LLC (herein “Brain Sentinel”) announces the global launch of its new SeizureLink™ Alerting System at the Epilepsy Foundation’s “2018 Epilepsy Pipeline Conference”, currently being held in San Francisco, CA. Pre-ordering for the U.S. will begin in March 2018, with shipments planned to begin by mid-summer via SeizureLink.com. ...
-
Epihunter awarded $200k grant to support the commercialization of its AI seizure detection algorithm
Belgian health tech startup epihunter NV is awarded a $200,000 grant from Epilepsy Foundation to further validate and market their CE labelled epileptic seizure detection algorithm. “The objective seizure data collected by epihunter can help clinicians make more informed treatment decisions,” says Dr Alexander Rotenberg, neurologist at Boston Children’s Hospital and ...
By Epihunter NV
-
Brain Sentinel, Inc. Announces New FDA 510(k) Clearance for its First-in-Class SPEAC® System Helping Physicians Characterize Seizure Events
Brain Sentinel, Inc., manufacturer of the first FDA-cleared portable seizure monitoring and alerting technology utilizing surface electromyography (sEMG), announced that its SPEAC® System has received a new 510(k) clearance of expanded indications from the U.S. Food and Drug Administration (FDA). Brain Sentinel, Inc., manufacturer of the first FDA-cleared portable seizure monitoring ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you